Organon & Co. Common Stock (NY:OGN)

Learn how these three healthcare stocks offer sharp opportunities in pharmaceuticals, healthcare services, and biotechnology.

3 Healthcare Stocks With the Potential to Triple Your Investment by 2026

May 01, 2024

Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024

April 08, 2024

Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints

April 08, 2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.

Thursday Is Your Last Chance To Buy Organon Before The Dividend Payout

February 20, 2024

Via Benzinga

Earnings Scheduled For February 15, 2024

February 15, 2024

Via Benzinga

Organon's Earnings: A Preview

February 14, 2024

Via Benzinga

Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields

March 13, 2024

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

Turn $500 into a Fortune: 3 Top Stock Picks for March’s Million-Dollar Rally

March 07, 2024

Here are three top stock picks for rally have their grip in travel, packaged foods, meats and pharmaceuticals.

In a welcome move, drug maker Organon stock saw its Relative Strength Rating rise from 66 to 71 on Wednesday.

5 Value Stocks In The Healthcare Sector

March 04, 2024

Via Benzinga

Drug Maker Organon Stock Scores Relative Strength Upgrade

February 28, 2024

Via Investor's Business Daily

Under the Radar: 3 Overlooked Stocks Ready to Dominate the Market

February 26, 2024

Explore growth strategies of overlooked stocks with strong fundamentals in strategic investments and market expansion.

New York Attorney General Urges FDA Action On Widely Used Asthma Drug's Concerns Over Pediatric Safety

February 26, 2024

The Attorney General of New York, Letitia James, has called on the FDA to address safety risks associated with the widely used asthma and allergy medicine Singulair (montelukast).

Via Benzinga

Looking Into Organon's Recent Short Interest

January 22, 2024

Via Benzinga

Why Organon & Co. Stock Popped Today

January 10, 2024

Organon & Co. (NYSE: OGN) shares traded higher on Wednesday after the company announced the availability of XACIATO 2% by prescription.

Via Benzinga

Don't Overlook These Low-Risk High-Dividend Yielding Stocks

February 24, 2024

Given the rally in the S&P 500 and the Nasdaq over the last year, it may be wise to consider stocks that should be less volatile during market corrections. Even better is when stocks have dividend...

Via Talk Markets

Topics Stocks

First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks

February 21, 2024

Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of awareness. ARPA-H Sprint for Women's Health aims to promote innovative solutions.

Via Benzinga

Organon Announces HADLIMA™ (adalimumab-bwwd) Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary

February 20, 2024

Organon exceeds Q4 2023 revenue expectations, reaching $1.6 billion. Women's Health thrives with 7% revenue increase, driven by Follistim AQ's 63% growth. Biosimilar revenue surges by 49%.

Why Is Women Health-Focused Organon Stock Trading Higher On Thursday?

February 15, 2024

Via Benzinga

Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

February 15, 2024

Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings.

Via Benzinga

Reliance Steel & Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday

February 15, 2024

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday.

Via Benzinga

Topics Stocks

Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2023

February 15, 2024

Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 15, 2024

February 01, 2024

Did You Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts?

January 30, 2024

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector

January 29, 2024

Via Benzinga

Beat Inflation With These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts

January 12, 2024

Via Benzinga

Topics Economy

Organon’s XACIATO™ (clindamycin phosphate) Vaginal Gel 2% Available Nationwide to Treat Bacterial Vaginosis (BV) in Females Aged 12 and Older

January 10, 2024

Up 5.7% year-to-date, pharmaceuticals - including MRK - are the best performing industry in the entire U.S. equity market, outpacing even biotech stocks.

Merck, the Dow's hottest stock, gets set to report Q4 financials

January 08, 2024

Via MarketBeat

Topics Stocks

Organon affirms 2023 revenue and Adjusted EBITDA guidance and provides 2024 outlook

January 08, 2024